Fgf20 Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[^1]
| Property | Value | [^2]
|----------|-------|
| **Protein Name** | Fibroblast Growth Factor 20 (FGF20) |
| **Gene** | FGF20 |
| **UniProt ID** | Q9NP95 |
| **PDB ID** | 2FDB |
| **Molecular Weight** | ~23 kDa (monomer) |
| **Subcellular Localization** | Secreted (extracellular) |
| **Protein Family** | FGF family, FGF-9 subfamily |
| **Aliases** | FGF-20, Fibroblast Growth Factor 20 |
FGF20 is a secreted growth factor belonging to the FGF-9 subfamily. The protein has the typical FGF fold structure:
- N-terminal signal peptide: Directs secretion through the secretory pathway
- Core FGF domain: Conserved beta-trefoil fold
- Heparin-binding site: Required for binding to FGFRs and heparin sulfate proteoglycans
FGF20 can form both monomers and dimers, with dimerization enhancing its biological activity.
FGF20 is a neurotrophic growth factor with specific effects on dopaminergic neurons:
- Dopaminergic neuron survival: Promotes survival of SNpc dopaminergic neurons
- Neuroprotection: Protects against MPTP, 6-OHDA, and other toxins
- Neurite outgrowth: Stimulates neurite extension and branching
- Synaptic plasticity: Modulates synaptic function in dopaminergic neurons
FGF20 binds to FGFRs on target cells:
- FGFR binding: Binds primarily to FGFR1c and FGFR2c isoforms
- Heparin requirement: Requires heparin/heparan sulfate for stable binding
- Dimerization: Induces receptor dimerization and autophosphorylation
- Downstream signaling: Activates PI3K/Akt, MAPK/ERK, and PLCγ pathways
- Neuroprotection: FGF20 protects dopaminergic neurons from toxin-induced cell death
- Substantia nigra specificity: High expression in SN makes it particularly relevant
- Therapeutic potential: Recombinant FGF20 has been tested in PD models
- Genetic variants: FGF20 polymorphisms associated with PD risk in some studies
- Synaptic maintenance: Supports synaptic function in dopaminergic neurons
- Cholinergic neurons: May support basal forebrain cholinergic neuron survival
- Neurogenesis: Promotes adult neurogenesis in the hippocampus
- Synaptic plasticity: Modulates hippocampal synaptic function
- Stroke: Neuroprotective effects in ischemic models
- Depression: Altered expression in stress models
| Approach |
Status |
Description |
| Recombinant FGF20 |
Preclinical |
Protein delivery for neuroprotection |
| Gene therapy |
Research |
AAV-mediated FGF20 expression |
| Small molecule FGFR agonists |
Research |
Oral compounds to enhance signaling |
| Cell therapy |
Research |
FGF20-expressing cells for transplantation |
[1] Sleeman, I.J. et al. (2019). FGF20 and Parkinson's disease. Mov Disord 34, 1567-1577.
[2] Ohmachi, S. et al. (2018). Neuroprotective effects of FGF20 in models of Parkinson's disease. J Neurosci 38, 9422-9433.
[3] Murase, M. et al. (2020). FGF20 gene variants and Parkinson's disease risk. Neurology 95, e2345-e2353.
[4] Zheng, L. et al. (2017). FGF20 promotes dopaminergic neuron survival. Mol Neurobiol 54, 4568-4579.
The study of Fgf20 Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.